 | • レポートコード：MRC2305A042 • 出版社/出版日：Transparency Market Research / 2023年3月30日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートによると、世界の研究用抗体＆試薬市場規模が、2023年の111億ドルから2033年に230億ドルとなり、予測期間中に年平均6.6%で成長すると推測されています。本レポートは、研究用抗体＆試薬の世界市場について徹底的に分析・調査を行い、エグゼクティブサマリー、市場概要、市場背景、製品別（試薬、抗体）分析、形態別（モノクローナル抗体、ポリクローナル抗体、組換え抗体）分析、ソース別（マウス、ウサギ、その他）分析、技術別（ウェスタンブロッティング、フローサイトメトリー、酵素結合免疫吸着法、免疫組織化学、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の項目を整理しています。また、Thermo Fisher Scientific, Inc.、Merck KGaA、Abcam Plc、Becton, Dickinson, and Company、Bio-Rad Laboratories、Cell Signaling Technologies、F. Hoffman-La Roche、Danaher Corporation、Agilent Technologies、PerkinElmer、Lonza、GenScript、BioLegend、Illumina, Inc.、Fujirebio Diagnostics, Incなど、主要企業情報を含んでいます。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・世界の研究用抗体＆試薬市場規模：製品別 - 試薬の市場規模 - 抗体の市場規模 ・世界の研究用抗体＆試薬市場規模：形態別 - モノクローナル抗体の市場規模 - ポリクローナル抗体の市場規模 - 組換え抗体の市場規模 ・世界の研究用抗体＆試薬市場規模：ソース別 - マウスにおける市場規模 - ウサギにおける市場規模 - その他ソースにおける市場規模 ・世界の研究用抗体＆試薬市場規模：技術別 - ウェスタンブロッティングにおける市場規模 - フローサイトメトリーにおける市場規模 - 酵素結合免疫吸着法における市場規模 - 免疫組織化学における市場規模 - その他技術における市場規模 ・世界の研究用抗体＆試薬市場規模：地域別 - 北米の研究用抗体＆試薬市場規模 - 中南米の研究用抗体＆試薬市場規模 - ヨーロッパの研究用抗体＆試薬市場規模 - アジア太平洋の研究用抗体＆試薬市場規模 - 中東・アフリカの研究用抗体＆試薬市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Research Antibodies and Reagents Market – Scope of Report
TMR’s report on the global research antibodies and reagents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global research antibodies and reagents market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global research antibodies and reagents market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the research antibodies and reagents market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global research antibodies and reagents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global research antibodies and reagents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global research antibodies and reagents market.
The report delves into the competitive landscape of the global research antibodies and reagents market. Key players operating in the global research antibodies and reagents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global research antibodies and reagents market profiled in this report.
Key Questions Answered in Global Research Antibodies and Reagents Market Report
• What is the sales/revenue generated by research antibodies and reagents across all regions during the forecast period?
• What are the opportunities in the global research antibodies and reagents market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Research Antibodies and Reagents Market – Research Objectives and Research Approach
The comprehensive report on the global research antibodies and reagents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global research antibodies and reagents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global research antibodies and reagents market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
5.3.1. Reagent
5.3.1.1. Media & Sera
5.3.1.2. Stains & Dyes
5.3.1.3. Fixatives
5.3.1.4. Buffers
5.3.1.5. Solvents
5.3.1.6. Enzymes
5.3.1.7. Probes
5.3.1.8. Other Reagents
5.3.2. Antibodies
5.3.2.1. Primary Antibodies
5.3.2.2. Secondary Antibodies
5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Form, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Form, 2023-2033
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Recombinant Antibodies
6.4. Y-o-Y Growth Trend Analysis By Form, 2018-2022
6.5. Absolute $ Opportunity Analysis By Form, 2023-2033
7. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Source
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
7.3.1. Mice
7.3.2. Rabbit
7.3.3. Other Sources
7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023-2033
8.3.1. Weatern Blotting
8.3.2. Flow Cytometry
8.3.3. Enzyme-linked Immunosorbent Assay
8.3.4. Immunohistochemistry
8.3.5. Immunofluorescence
8.3.6. Immunoprecipitation
8.3.7. Other Technologies
8.4. Y-o-Y Growth Trend Analysis By Technology, 2018-2022
8.5. Absolute $ Opportunity Analysis By Technology, 2023-2033
9. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033
9.3.1. Proteomics
9.3.2. Drug Development
9.3.3. Genomics
9.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022
9.5. Absolute $ Opportunity Analysis By Application, 2023-2033
10. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
10.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
10.3.1. Pharmaceutical & Biotechnologies Industries
10.3.2. Academic & Research Institutions
10.3.3. Contract Research Organizations
10.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
10.5. Absolute $ Opportunity Analysis By End User, 2023-2033
11. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Region
11.1. Introduction
11.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
11.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. U.S.
12.2.1.2. Canada
12.2.2. By Product
12.2.3. By Form
12.2.4. By Source
12.2.5. By Technology
12.2.6. By Application
12.2.7. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Form
12.3.4. By Source
12.3.5. By Technology
12.3.6. By Application
12.3.7. By End User
12.4. Key Takeaways
13. Latin America Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. Brazil
13.2.1.2. Mexico
13.2.1.3. Rest of Latin America
13.2.2. By Product
13.2.3. By Form
13.2.4. By Source
13.2.5. By Technology
13.2.6. By Application
13.2.7. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Form
13.3.4. By Source
13.3.5. By Technology
13.3.6. By Application
13.3.7. By End User
13.4. Key Takeaways
14. Europe Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. U.K.
14.2.1.2. Spain
14.2.1.3. Germany
14.2.1.4. Italy
14.2.1.5. France
14.2.1.6. Rest of Europe
14.2.2. By Product
14.2.3. By Form
14.2.4. By Source
14.2.5. By Technology
14.2.6. By Application
14.2.7. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Form
14.3.4. By Source
14.3.5. By Technology
14.3.6. By Application
14.3.7. By End User
14.4. Key Takeaways
15. Asia Pacific Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
15.2.1. By Country
15.2.1.1. India
15.2.1.2. China
15.2.1.3. Japan
15.2.1.4. Rest of Asia Pacific
15.2.2. By Product
15.2.3. By Form
15.2.4. By Source
15.2.5. By Technology
15.2.6. By Application
15.2.7. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Form
15.3.4. By Source
15.3.5. By Technology
15.3.6. By Application
15.3.7. By End User
15.4. Key Takeaways
16. Middle East and Africa Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
16.2.1. By Country
16.2.1.1. South Africa
16.2.1.2. GCC Countries
16.2.1.3. Rest of Middle East and Africa
16.2.2. By Product
16.2.3. By Form
16.2.4. By Source
16.2.5. By Technology
16.2.6. By Application
16.2.7. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Form
16.3.4. By Source
16.3.5. By Technology
16.3.6. By Application
16.3.7. By End User
16.4. Key Takeaways
17. Key Countries Research Antibodies & Reagents Market Analysis
17.1. U.S.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product
17.1.2.2. By Form
17.1.2.3. By Source
17.1.2.4. By Technology
17.1.2.5. By Application
17.1.2.6. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product
17.2.2.2. By Form
17.2.2.3. By Source
17.2.2.4. By Technology
17.2.2.5. By Application
17.2.2.6. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product
17.3.2.2. By Form
17.3.2.3. By Source
17.3.2.4. By Technology
17.3.2.5. By Application
17.3.2.6. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product
17.4.2.2. By Form
17.4.2.3. By Source
17.4.2.4. By Technology
17.4.2.5. By Application
17.4.2.6. By End User
17.5. U.K.
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product
17.5.2.2. By Form
17.5.2.3. By Source
17.5.2.4. By Technology
17.5.2.5. By Application
17.5.2.6. By End User
17.6. Spain
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product
17.6.2.2. By Form
17.6.2.3. By Source
17.6.2.4. By Technology
17.6.2.5. By Application
17.6.2.6. By End User
17.7. Germany
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product
17.7.2.2. By Form
17.7.2.3. By Source
17.7.2.4. By Technology
17.7.2.5. By Application
17.7.2.6. By End User
17.8. Italy
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product
17.8.2.2. By Form
17.8.2.3. By Source
17.8.2.4. By Technology
17.8.2.5. By Application
17.8.2.6. By End User
17.9. France
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product
17.9.2.2. By Form
17.9.2.3. By Source
17.9.2.4. By Technology
17.9.2.5. By Application
17.9.2.6. By End User
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product
17.10.2.2. By Form
17.10.2.3. By Source
17.10.2.4. By Technology
17.10.2.5. By Application
17.10.2.6. By End User
17.11. China
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product
17.11.2.2. By Form
17.11.2.3. By Source
17.11.2.4. By Technology
17.11.2.5. By Application
17.11.2.6. By End User
17.12. Japan
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product
17.12.2.2. By Form
17.12.2.3. By Source
17.12.2.4. By Technology
17.12.2.5. By Application
17.12.2.6. By End User
17.13. Australia & New Zealand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product
17.13.2.2. By Form
17.13.2.3. By Source
17.13.2.4. By Technology
17.13.2.5. By Application
17.13.2.6. By End User
17.14. South Africa
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product
17.14.2.2. By Form
17.14.2.3. By Source
17.14.2.4. By Technology
17.14.2.5. By Application
17.14.2.6. By End User
17.15. GCC Countries
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product
17.15.2.2. By Form
17.15.2.3. By Source
17.15.2.4. By Technology
17.15.2.5. By Application
17.15.2.6. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Form
18.3.4. By Source
18.3.5. By Technology
18.3.6. By Application
18.3.7. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Thermo Fisher Scientific, Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Merck KGaA
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Abcam Plc
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Becton, Dickinson and Company
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Bio-Rad Laboratories
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Cell Signaling Technologies
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. F. Hoffman-La Roche
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Danaher Corporation
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Agilent Technologies
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. PerkinElmer
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.11. Lonza
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.12. GenScript
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.13. BioLegend
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.14. Illumina, Inc.
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.15. Fujirebio Diagnostics, Inc
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology